Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Terns Pharmaceuticals
Biotech
Tern oral GLP-1 shows 5% weight loss at one month, highest dose
Terns’ decision to drop its liver disease ambitions may pay off, after the biotech posted phase 1 data from its obesity candidate.
James Waldron
Sep 9, 2024 9:13am
Takeda taps new head of US oncology business—Chutes & Ladders
Aug 2, 2024 8:30am
Pfizer's obesity pill news leaves analysts wanting
Jul 12, 2024 10:17am
Terns' ex-MASH drug cuts fat, not muscle in GLP-1 combo in mice
Jun 25, 2024 8:51am
Sanofi, Pfizer, Acelyrin and more—Chutes & Ladders
May 10, 2024 8:30am
As Madrigal lands MASH nod, what's next for biotechs in pursuit?
Mar 15, 2024 10:55am
